Skip to main content

PharmacoEconomics

Ausgabe 12/2023

Inhalt (9 Artikel)

Editorial

The Carer QALY Trap and Altruism in Economic Evaluations

J. Mick Tilford, Aygul Tarlan

Open Access Current Opinion

Modelling Spillover Effects on Informal Carers: The Carer QALY Trap

David J. Mott, Hannah Schirrmacher, Hareth Al-Janabi, Sophie Guest, Becky Pennington, Nicolas Scheuer, Koonal K. Shah, Chris Skedgel

Scoping Review

Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Scoping Review of Economic Evaluations and Cost-of-Illness Studies

Deborah A. Marshall, Brittany Gerber, Diane L. Lorenzetti, Karen V. MacDonald, Riley Jewel Bohach, Gillian R. Currie

Open Access Systematic Review

Handling Missing Data in Health Economics and Outcomes Research (HEOR): A Systematic Review and Practical Recommendations

Kumar Mukherjee, Necdet B. Gunsoy, Rita M. Kristy, Joseph C. Cappelleri, Jessica Roydhouse, Judith J. Stephenson, David J. Vanness, Sujith Ramachandran, Nneka C. Onwudiwe, Sri Ram Pentakota, Helene Karcher, Gian Luca Di Tanna

Open Access Original Research Article

Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing Regimens

David Teigen, Robert O. Opoka, Phillip Kasirye, Catherine Nabaggala, Heather A. Hume, Bjørn Blomberg, Chandy C. John, Russell E. Ware, Bjarne Robberstad

Open Access Original Research Article

De Novo Cost-Effectiveness Model Framework for Nonalcoholic Steatohepatitis—Modeling Approach and Validation

Peter Gal, Gyorgyi Feldmajer, Margarida Augusto, Ray Gani, Emma Hook, Ash Bullement, Zoe Philips, Inger Smith

Open Access Original Research Article

Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland

Michaela Carla Barbier, Alicia Fengler, Esther Pardo, Arjun Bhadhuri, Niklaus Meier, Oliver Gautschi

Open Access Original Research Article

Capturing Value Attributes in the Economic Evaluation of Ceftazidime with Avibactam for Treating Severe Aerobic Gram-Negative Bacterial Infections in the United Kingdom

Jason Gordon, Maria Gheorghe, Simon Goldenberg, Ryan Miller, James Dennis, Amer Al-Taie